Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q2 FY25 Earnings Presentation
30 slides from Rossari Biotech's earnings presentation, Oct 20, 2024
Slide 1: Cover letter: Q2 FY25 Earnings Presentation
October 20, 2024 Dear Sir/Madam, Subject.: Q2 FY25 Earnings Presentation Please find enclosed a copy of the Earnings Presentation for the Quarter and half year ended September 30, 2024. The same may please be taken on record and suitably disseminated to all concerned. Thanking you, Yours Sincerely,
Slide 2: Q2 & H1 FY25 Results Presentation
Rossari Biotech Ltd. Q2 & H1 FY25 Results Presentation October 19, 2024
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to b
Slide 4: Q2 FY25 Results Overview, Company Overview, Annexure
Q2 FY25 Results Overview Company Overview Annexure 3
Slide 5: Q2 FY25 – Key Financial Highlights
Q2 FY25 – Key Financial Highlights Consistent Quarterly Performance Highest Quarterly Revenue Highest Quarterly EBITDA Highest Quarterly PAT Revenue from Operations EBITDA PAT Business Sector (Rs. cr) (Rs. cr) (Rs. cr) contribution 65.9 64.9 63.6 498.4 35.3 489.7 483.5 34.9 32.9 HPPC, 78% Q2 FY25 TS
Slide 6: Past Financial Performance Snapshot
Past Financial Performance Snapshot Revenue (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) CAGR – 11% CAGR – 16% CAGR – 16% 131 1,831 250 1,656 223 107 1,483 98 185 FY22 FY23 FY24 FY22 FY23 FY24 FY22 FY23 FY24 Exports (Rs. cr) ROE (%) ROCE (%) Net Debt to Equity (x) CAGR – 30% 24.0 448 21.0 21.0 380 0.04 265
Slide 7: Management Message
Management Message Commenting on the Q2 FY25 performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We have reported a steady performance this quarter, reflecting the resilience of our business amidst a dynamic m
Slide 8: Key Developments
Key Developments • Expanding Global Presence Driving Growth o Rossari Global DMCC, a wholly owned subsidiary of Rossari Biotech Limited (Rossari), has incorporated a step- down wholly owned subsidiary, Rossari Biotech Trading FZE, in the Jebel Ali Free Zone (JAFZA), UAE. This new entity will focus o
Slide 9: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Particulars (Rs. cr) Q2 FY25 Q2 FY24 Y-o-Y H1 FY25 H1 FY24 Y-o-Y Revenues from Operations 498.4 483.5 3.1% 988.0 894.1 10.5% Total Expenditure •COGS 340.7 342.8 -0.6% 681.6 632.3 7.8% •Employee benefits expense 32.6 27.5 18.5% 61.1 52.0 17.5% •Other expenses 59.
Slide 10: Consolidated Balance Sheet
Consolidated Balance Sheet EQUITY AND LIABILITIES CONSOLIDATED CONSOLIDATED ASSETS CONSOLIDATED CONSOLIDATED As on 30th Sept As on 31st March As on 30th Sept As on 31st March Particulars (Rs. crore) Particulars (Rs. crore) 2024 (un-Audited) 2024 (Audited) 2024 (un-Audited) 2024 (Audited) EQUITY ASSE
Slide 11: Consolidated Cash Flows
Consolidated Cash Flows As on 30th Sept As on 30th Sept As on 30th Sept As on 30th Sept Particulars (Rs. crore) Particulars (Rs. crore) 2024 (Unaudited) 2023 (Unaudited) 2024 (Unaudited) 2023 (Unaudited) Cash flows from operating activities Cash flows from investing activities Profit before tax 95.1
Slide 12: Segment-wise Operating Performance
Segment-wise Operating Performance Quarterly Revenue Break-up (Rs. cr) Q2 FY25 Q1 FY25 Q2 FY24 498 490 483 390 365 367 84 98 96 24 27 20 HPPC TSC AHN TOTAL Shift (Y-o-Y) % 6% -13% 20% 3% Shift (Q-o-Q) % 7% -14% -11% 2% Note: 1) All figures, unless mentioned otherwise, are on a consolidated basis 2)
Slide 13: Q2 FY25 Results Overview, Company Overview, Annexure
Q2 FY25 Results Overview Company Overview Annexure 12
Slide 14: Rossari – At a Glance
Rossari – At a Glance Technocrat promoters with 45+ 7* 338,100* 4* 34% 24% cumulative years of Manufacturing MTPA R&D Facilities Revenue CAGR % PAT CAGR % experience in the facilities Capacity Installed (FY19-23) (FY19-23) specialty chemicals industry Rossari – A Specialty-Chemical manufacturer prov
Slide 15: A 25-Year Journey of Transformation
A 25-Year Journey of Transformation Delivering Value and Maintaining Synergy Along the Way Looking back in time Our Company was initially incorporated as ‘Rossari Labtech’ in March, 2003, as a partnership firm. In the same year, in December, the name of the partnership firm was changed to ‘Rossari B
Slide 16: Business Overview
Business Overview One of the leading specialty chemicals manufacturer delivering differentiated & tailor-made solutions across Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC) and Animal Health and Nutrition (AHN) businesses HPPC TSC AHN • One of the fastest-gr
Slide 17: Strengthening Market Presence
Strengthening Market Presence Increasingly tapping new segments across domestic and international markets Building direct Growing client touch-points with base of over several clients 1,000 customers Strong and both India and long-standing International relationships with several clients and distrib
Slide 18: Robust Manufacturing Capabilities
Robust Manufacturing Capabilities Manufacturing Facility at Silvassa • Located on 8.6 acres of land • Fungible manufacturing capabilities for powders, granules and liquids • Facility has a comprehensive range of testing & packaging capabilities Unitop Dahej Plant • Effluent treatment facility, with
Slide 19: Growth Drivers
Growth Drivers 01 Augmenting product 02 Innovation and product 03 Seeding new business portfolio development lines • Enhance emphasis on green/sustainable • Strengthen innovation platform for • Evaluate opportunities based on existing solutions differentiated offerings capabilities and technical kno
Slide 20: Update on Key Subsidiaries
Update on Key Subsidiaries Executed synergistic acquisitions in the past complementing the ethos of Rossari’s business model Revenue (Rs. cr) CAGR – 20% • Unitop solutions sold across 25+ countries • Presence in high-potential Specialty chemical 651 554 454 Unitop Chemicals segments, such as Agroche
Slide 21: Key Synergies from Acquisitions
Key Synergies from Acquisitions Strategic & value-accretive acquisitions accelerate growth and drive economies of scale Augmented Expansion of Extension of Pooling together of Inorganic presence in addressable manufacturing related technologies investments within Specialty Chemical, domestic and exp
Slide 22: Strategic Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 1. Expanding into New Business Lines • Leverage existing R&D capabilities and expertise in core chemistries to • Diversified revenue streams, reduced risk from dependence on core diversify into new product segments. segments. • Exp
Slide 23: Strategic Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 4. Enhancing Sustainability and Green Initiatives • Invest in research and development of advanced sustainable chemical • Strengthened brand reputation as an environmentally responsible solutions. company. • Explore opportunities i
Slide 24: Strategic Responses to Threats
Strategies Strategic Responses to Threats Threats Outcomes 1. Increasing Competition • Entry of new players or intensified competition from existing rivals in the • Drive for innovation and development of differentiated products specialty chemicals market. • Improved operational efficiency and cost
Slide 25: Focus on Green & Sustainable Chemical Solutions since Inception
Focus on Green & Sustainable Chemical Solutions since Inception Specialists in producing environmentally-benign substitutes that replace legacy and harmful products Focus on green, sustainable and cost neutral products Minimizing carbon footprint of manufacturing processes while maximizing customer
Slide 26: Corporate Social Responsibility
Corporate Social Responsibility We at Rossari, recognize our role and responsibility to deliver superior and sustainable value to our customers, business partners, employees and communities. We have implemented various CSR initiatives with employee volunteers as well as in partnership with implement
Slide 27: Experienced Promoters and Board of Directors
Experienced Promoters and Board of Directors Founders & Promoters Independent Directors • B. Sc. (chemistry major) from K. J. Somaiya College of Science, • B. Com. from H. L. Commerce College, Gujarat University & associate member of ICAI University of Bombay & B. Sc. (technology) in textile chemist
Slide 28: Conference Call Details
CONFERENCE CALL DETAILS Q2 F Y 2 0 2 5 Earnings C o n f er ence Call Time 05:00 PM IST on Monday, October 21, 2024 Pre-registration To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Diamond Pass Registration
Slide 29: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Specialty-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvas
Slide 30: Thank you
Thank y#u